Growth Metrics

ENDRA Life Sciences (NDRA) Total Non-Current Liabilities (2019 - 2021)

Historic Total Non-Current Liabilities for ENDRA Life Sciences (NDRA) over the last 3 years, with Q1 2021 value amounting to $280829.0.

  • ENDRA Life Sciences' Total Non-Current Liabilities fell 1380.43% to $280829.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $280829.0, marking a year-over-year decrease of 1380.43%. This contributed to the annual value of $608992.0 for FY2020, which is 7764.61% up from last year.
  • As of Q1 2021, ENDRA Life Sciences' Total Non-Current Liabilities stood at $280829.0, which was down 1380.43% from $608992.0 recorded in Q4 2020.
  • ENDRA Life Sciences' Total Non-Current Liabilities' 5-year high stood at $645450.0 during Q2 2020, with a 5-year trough of $280829.0 in Q1 2021.
  • In the last 3 years, ENDRA Life Sciences' Total Non-Current Liabilities had a median value of $358915.0 in 2019 and averaged $455767.9.
  • In the last 5 years, ENDRA Life Sciences' Total Non-Current Liabilities soared by 7764.61% in 2020 and then crashed by 1380.43% in 2021.
  • Over the past 3 years, ENDRA Life Sciences' Total Non-Current Liabilities (Quarter) stood at $342812.0 in 2019, then surged by 77.65% to $608992.0 in 2020, then tumbled by 53.89% to $280829.0 in 2021.
  • Its last three reported values are $280829.0 in Q1 2021, $608992.0 for Q4 2020, and $627573.0 during Q3 2020.